ACCESSION: MSBNK-SMB_Measured-HSA001P0324014
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 35
COMMENT: RAW_SPEC {'3_posi_12648': {'bp': 36421.0, 'sum': 120743.0}, '12_posi_12966': {'bp': 25528.0, 'sum': 76503.0}, '3_posi_13341': {'bp': 27132.0, 'sum': 98500.0}, '4_posi_12441': {'bp': 27229.0, 'sum': 103074.0}, '5_posi_12441': {'bp': 29045.0, 'sum': 93280.0}, '12_posi_12839': {'bp': 29302.0, 'sum': 120325.0}, '5_posi_12944': {'bp': 26786.0, 'sum': 109122.0}, '6_posi_12711': {'bp': 22812.0, 'sum': 88172.0}, '15_posi_12024': {'bp': 30349.0, 'sum': 105454.0}, '8_posi_13135': {'bp': 34517.0, 'sum': 132676.0}, '6_posi_13132': {'bp': 24770.0, 'sum': 94986.0}, '15_posi_13195': {'bp': 27837.0, 'sum': 127838.0}, '11_posi_12065': {'bp': 32568.0, 'sum': 141336.0}, '9_posi_13177': {'bp': 25359.0, 'sum': 102379.0}, '9_posi_12232': {'bp': 31768.0, 'sum': 101165.0}, '13_posi_12019': {'bp': 31182.0, 'sum': 114593.0}, 'BLK02_12146': {'bp': 34108.0, 'sum': 152770.0}, '11_posi_12318': {'bp': 31690.0, 'sum': 135824.0}, 'ProcedureBlank_13133': {'bp': 30028.0, 'sum': 118739.0}, '12_posi_12712': {'bp': 28918.0, 'sum': 105799.0}, '1_posi_12611': {'bp': 23647.0, 'sum': 74289.0}, '5_posi_13132': {'bp': 29546.0, 'sum': 136705.0}, '13_posi_12083': {'bp': 28691.0, 'sum': 111959.0}, '11_posi_13280': {'bp': 24374.0, 'sum': 103580.0}, '19_posi_12230': {'bp': 19652.0, 'sum': 58930.0}, '5_posi_12275': {'bp': 32832.0, 'sum': 128833.0}, '4_posi_12251': {'bp': 31579.0, 'sum': 154038.0}, '1_posi_12210': {'bp': 31536.0, 'sum': 129754.0}, '17_posi_12715': {'bp': 23330.0, 'sum': 89642.0}, '6_posi_12064': {'bp': 21847.0, 'sum': 92160.0}, '9_posi_12674': {'bp': 28809.0, 'sum': 97167.0}, '14_posi_12885': {'bp': 21701.0, 'sum': 81927.0}, 'ProcedureBlank_12611': {'bp': 28251.0, 'sum': 114868.0}, 'ProcedureBlank_13323': {'bp': 25723.0, 'sum': 110487.0}, 'ProcedureBlank_12276': {'bp': 28499.0, 'sum': 107140.0}}
COMMENT: RETENTION_TIME_STDEV 0.870
COMMENT: PRECURSOR_M/Z_RAW 324.216278
COMMENT: PRECURSOR_M/Z_STDEV 0.000106
COMMENT: PRECURSOR_IN_MS1 mz 324.216936; int 33.444; delta(ppm) 1.387859
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.000; C18H29NO4; [M+H]+; delta(ppm) -0.000000
COMMENT: PROPOSED_MF MS-FINDER 3.780; C18H29NO4; [M+H]+; delta(ppm) -0.002629
COMMENT: PROPOSED_MF MS-FINDER 2.413; C11H37N3OS3; [M+H]+; delta(ppm) -0.673180
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.921; C18H29NO4; [M+H]+; delta(ppm) -0.002629
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.782; C14H25N7O2; [M+H]+; delta(ppm) 8.279941
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.139; C12H30N5O3P; [M+H]+; delta(ppm) 3.185248
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.115; C15H31O7; [M+H]+; delta(ppm) 8.263749
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.962; C13H30ClN5O2; [M+H]+; delta(ppm) -68920.268394
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.815; C11H26FN7O3; [M+H]+; delta(ppm) 4.755545
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.544; C15H30FNO5; [M+H]+; delta(ppm) -3.526967
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.766; C11H29N7O2S; [M+H]+; delta(ppm) -2.117876
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.111; C16H27N4O3; [M+H]+; delta(ppm) 4.138639
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.517; C16H31F2NOS; [M+H]+; delta(ppm) 0.666066
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C18H29NO4; [M+H]+; delta(ppm) -0.002629
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.381; AKLNLVOZXMQGSI-UHFFFAOYNA-N; [M+H]+; bufetolol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.333; JTRRPZVFSRBZIV-UHFFFAOYSA-N; [M+H]+; 5-{[(3-hydroxypropyl)amino]methyl}-10,14-dimethyl-2,7-dioxatetracyclo[8.4.0.0?,?.0?,?]tetradecan-6-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.299; PKMWXNTYYZTJQQ-UHFFFAOYSA-N; [M+H]+; 3-{[2-(dimethylamino)ethoxy]carbonyl}-8,8-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.299; SQDFUMNRZHDLGQ-UHFFFAOYSA-N; [M+H]+; 3-{[2-(dimethylazaniumyl)ethoxy]carbonyl}-5,5-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.447; IBZYPBGPOGJMBF-VOTSOKGWNA-N; [M+H]+; N-Jasmonoylisoleucine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.266; JNDJPKHYZWRRIS-UHFFFAOYNA-N; [M+H]+; cicloprolol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.258; JKVULIFEVYXDTC-UHFFFAOYSA-N; [M+H]+; 4-({[(3-ethoxy-4-methoxyphenyl)methyl]amino}methyl)-2,2-dimethyloxan-4-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.238; ZHMNKOPAHVBXQW-SYSZZGASNA-N; [M+H]+; Lycofawcine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.229; PPVFOZYARYOARE-UHFFFAOYSA-N; [M+H]+; guaiapate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.215; WGYOXLHUEHBVOF-UHFFFAOYSA-N; [M+H]+; 1-[4-(1-hydroxypropyl)-2-methoxyphenoxy]-3-(piperidin-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.186; SFLJQCLAPBTFNR-BPRAKBJFNA-N; [M+H]+; Brevisamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.134; LWJJYAYQOTXATC-IZZDOVSWSA-N; [M+H]+; 3-tigloyloxy-6-(2'-methylbutyryloxy)tropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.134; RNJWVOJSSZQWNZ-KPKJPENVSA-N; [M+H]+; 3-tigloyloxy-6-methylbutyryloxytropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.134; NLDRTHCIVHPBQA-OXMGLSMJNA-N; [M+H]+; UNPD92339
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.134; NUHKGPDBRUDFLM-PHYFOSRJNA-N; [M+H]+; UNPD186010
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.134; RQTCBECAUUINSD-GXGMXFMGNA-N; [M+H]+; UNPD95697
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.134; VOZGUTOOTJYSLX-NJCZDKFDNA-N; [M+H]+; UNPD177764
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.134; FFRMROQLCVKCCL-PUWZGUPBSA-N; [M+H]+; Bipolamide A
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.082; CZCNCPSVLLDKPE-UHFFFAOYSA-N; [M+H]+; 18-nitrooctadeca-9,12,15-trienoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.082; ZSFRGYXNXUCYAK-PDBXOOCHSA-N; [M+H]+; (9Z,12Z,15Z)-2-nitrooctadeca-9,12,15-trienoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.082; AZDHNVVDNXRURH-UHFFFAOYSA-N; [M+H]+; 6-{[2-(dimethylazaniumyl)ethoxy]carbonyl}-2,3-dimethyl-5-(2-methylprop-1-en-1-yl)cyclohex-3-ene-1-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.082; BDUIIOHQSYPXRT-UHFFFAOYSA-N; [M+H]+; 4-methyl-2-{2-[3-oxo-2-(pent-2-en-1-yl)cyclopentyl]acetamido}pentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.082; MGGGOCSKDLGISA-UHFFFAOYSA-N; [M+H]+; 3-oxo-N-(2-oxooxolan-3-yl)tetradec-7-enamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.082; MICLDTZEBPLQFX-UHFFFAOYSA-N; [M+H]+; l-isoleucine, n-[[(1s,3as,6r,7as)-6-ethyl-2,3,3a,6,7,7a-hexahydro-1-hydroxy-1h-inden-4-yl]carbonyl]-
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.082; MLVLRGDKFVUVPM-UHFFFAOYSA-N; [M+H]+; 2-{[2-(dimethylamino)ethoxy]carbonyl}-4-(4-methylpent-3-en-1-ylidene)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.082; MXAJYBDSRMKKOJ-UHFFFAOYSA-N; [M+H]+; N-{3,5a,9-trimethyl-2-oxo-dodecahydronaphtho[1,2-b]furan-8-yl}-2-methoxyacetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.082; SHTWMNOBENSPNY-UHFFFAOYSA-N; [M+H]+; 3-{[(3-hydroxypropyl)amino]methyl}-8a-methyl-decahydro-2H-spiro[naphtho[2,3-b]furan-5,2'-oxiran]-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.082; SVDGTPCLQKGRJP-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-1-(3-hydroxy-2-methoxypyrrolidin-1-yl)-4,8-dimethylundeca-3,6,8-trien-1-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.082; VLKLZZGHWBZISX-UHFFFAOYSA-N; [M+H]+; 3,5-di-tert-butyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; PKMWXNTYYZTJQQ-UHFFFAOYSA-N; [M+H]+; 3-{[2-(dimethylamino)ethoxy]carbonyl}-8,8-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SQDFUMNRZHDLGQ-UHFFFAOYSA-N; [M+H]+; 3-{[2-(dimethylazaniumyl)ethoxy]carbonyl}-5,5-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.996; AKLNLVOZXMQGSI-UHFFFAOYNA-N; [M+H]+; bufetolol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; IBZYPBGPOGJMBF-VOTSOKGWNA-N; [M+H]+; N-Jasmonoylisoleucine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SFLJQCLAPBTFNR-BPRAKBJFNA-N; [M+H]+; Brevisamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ZHMNKOPAHVBXQW-SYSZZGASNA-N; [M+H]+; Lycofawcine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JNDJPKHYZWRRIS-UHFFFAOYNA-N; [M+H]+; cicloprolol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; PPVFOZYARYOARE-UHFFFAOYSA-N; [M+H]+; guaiapate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; LWJJYAYQOTXATC-IZZDOVSWSA-N; [M+H]+; 3-tigloyloxy-6-(2'-methylbutyryloxy)tropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; RNJWVOJSSZQWNZ-KPKJPENVSA-N; [M+H]+; 3-tigloyloxy-6-methylbutyryloxytropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NLDRTHCIVHPBQA-OXMGLSMJNA-N; [M+H]+; UNPD92339
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NUHKGPDBRUDFLM-PHYFOSRJNA-N; [M+H]+; UNPD186010
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; RQTCBECAUUINSD-GXGMXFMGNA-N; [M+H]+; UNPD95697
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; VOZGUTOOTJYSLX-NJCZDKFDNA-N; [M+H]+; UNPD177764
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; CZCNCPSVLLDKPE-UHFFFAOYSA-N; [M+H]+; 18-nitrooctadeca-9,12,15-trienoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ZSFRGYXNXUCYAK-PDBXOOCHSA-N; [M+H]+; (9Z,12Z,15Z)-2-nitrooctadeca-9,12,15-trienoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; FFRMROQLCVKCCL-PUWZGUPBSA-N; [M+H]+; Bipolamide A
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; AZDHNVVDNXRURH-UHFFFAOYSA-N; [M+H]+; 6-{[2-(dimethylazaniumyl)ethoxy]carbonyl}-2,3-dimethyl-5-(2-methylprop-1-en-1-yl)cyclohex-3-ene-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; BDUIIOHQSYPXRT-UHFFFAOYSA-N; [M+H]+; 4-methyl-2-{2-[3-oxo-2-(pent-2-en-1-yl)cyclopentyl]acetamido}pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JKVULIFEVYXDTC-UHFFFAOYSA-N; [M+H]+; 4-({[(3-ethoxy-4-methoxyphenyl)methyl]amino}methyl)-2,2-dimethyloxan-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JTRRPZVFSRBZIV-UHFFFAOYSA-N; [M+H]+; 5-{[(3-hydroxypropyl)amino]methyl}-10,14-dimethyl-2,7-dioxatetracyclo[8.4.0.0?,?.0?,?]tetradecan-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; MGGGOCSKDLGISA-UHFFFAOYSA-N; [M+H]+; 3-oxo-N-(2-oxooxolan-3-yl)tetradec-7-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; MICLDTZEBPLQFX-UHFFFAOYSA-N; [M+H]+; l-isoleucine, n-[[(1s,3as,6r,7as)-6-ethyl-2,3,3a,6,7,7a-hexahydro-1-hydroxy-1h-inden-4-yl]carbonyl]-
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; MLVLRGDKFVUVPM-UHFFFAOYSA-N; [M+H]+; 2-{[2-(dimethylamino)ethoxy]carbonyl}-4-(4-methylpent-3-en-1-ylidene)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; MXAJYBDSRMKKOJ-UHFFFAOYSA-N; [M+H]+; N-{3,5a,9-trimethyl-2-oxo-dodecahydronaphtho[1,2-b]furan-8-yl}-2-methoxyacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SHTWMNOBENSPNY-UHFFFAOYSA-N; [M+H]+; 3-{[(3-hydroxypropyl)amino]methyl}-8a-methyl-decahydro-2H-spiro[naphtho[2,3-b]furan-5,2'-oxiran]-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SVDGTPCLQKGRJP-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-1-(3-hydroxy-2-methoxypyrrolidin-1-yl)-4,8-dimethylundeca-3,6,8-trien-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; VLKLZZGHWBZISX-UHFFFAOYSA-N; [M+H]+; 3,5-di-tert-butyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; WGYOXLHUEHBVOF-UHFFFAOYSA-N; [M+H]+; 1-[4-(1-hydroxypropyl)-2-methoxyphenoxy]-3-(piperidin-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.507; AKLNLVOZXMQGSI-UHFFFAOYSA-N; [M+H]+; 1-(tert-butylamino)-3-[2-(oxolan-2-ylmethoxy)phenoxy]propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.266; JNDJPKHYZWRRIS-UHFFFAOYSA-N; [M+H]+; 1-[4-[2-(cyclopropylmethoxy)ethoxy]phenoxy]-3-(propan-2-ylamino)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; AFZPMFFKUZAFPS-UHFFFAOYSA-N; [M+H]+; 2-(diethylamino)ethyl 2-butoxy-3-methoxybenzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; GUKYZZSKXIILLI-UHFFFAOYSA-N; [M+H]+; 2-(butylamino)ethyl 2-butoxy-3-methoxybenzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.078; IBZYPBGPOGJMBF-QRHMYKSGSA-N; [M+H]+; (2S,3S)-3-methyl-2-[[2-[(1R,2R)-3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.732; XFLILAJQDVNDTB-UHFFFAOYSA-N; [M+H]+; 1-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3-(propoxymethyl)phenyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.647; PPVFOZYARYOARE-UHFFFAOYSA-N; [M+H]+; 1-[2-[2-[2-(2-methoxyphenoxy)ethoxy]ethoxy]ethyl]piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; JNLHPPFPJXHLKE-UHFFFAOYSA-N; [M+H]+; methyl 2-[2-hydroxy-3-(propan-2-ylamino)propoxy]-6-methyl-3-propan-2-ylbenzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; RNPFYZLWVMKCHI-BUSXIPJBSA-N; [M+H]+; [(7S)-7-pentanoyloxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl pentanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; SNFZSVZRZFZVIV-UHFFFAOYSA-N; [M+H]+; ethyl 2-[3-(dimethylamino)-2-hydroxypropoxy]-6-methyl-3-propan-2-ylbenzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; PIEVOKXIIFZVQL-UONOGXRCSA-N; [M+H]+; [(7S,8R)-7-(2,2-dimethylpropanoyloxy)-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl 2,2-dimethylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; CCMGNXCIXYOAOL-UHFFFAOYSA-N; [M+H]+; 1-[3-(ethoxymethyl)-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; KFJRWDSGXLCBSG-UHFFFAOYSA-N; [M+H]+; 1-[4-[2-hydroxy-3-(propylamino)propoxy]-3-(propoxymethyl)phenyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; CAAJQOXWAVAKRL-HMXJURRTSA-N; [M+H]+; 2-(dimethylamino)ethyl (2E)-2-[(6S)-6-acetyloxy-3,4,4a,5,6,7,8,8a-octahydro-1H-naphthalen-2-ylidene]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; CCOJZFVKVMICEM-UHFFFAOYSA-N; [M+H]+; 1-[2-[2-hydroxy-3-(propan-2-ylamino)propoxy]-5-(propoxymethyl)phenyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; SJCMIKOLENLLHD-UHFFFAOYSA-N; [M+H]+; 1-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3-(propan-2-yloxymethyl)phenyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; IEFBSRPZXVDVKT-UHFFFAOYSA-N; [M+H]+; 1-[4-[3-(tert-butylamino)-2-hydroxypropoxy]-3-(ethoxymethyl)phenyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; KCMGSZLKKRVNKG-UHFFFAOYSA-N; [M+H]+; ditert-butyl 4-prop-2-ynylpiperidine-1,4-dicarboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; XCYDUFDZEYUXTG-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-7-[(2-methylpropan-2-yl)oxycarbonylamino]adamantane-1-carboxylic acid
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C18H30N1O4; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 25.366
MS$FOCUSED_ION: PRECURSOR_M/Z 324.216934
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-0309000000-f11127ce93d8d3dca692
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  149.0234915 611.4996 149.023390 1.5098 117.29 1.0000 35 f{C8H5O3}/1.15ppm,p-C10H25N1O1
  324.2496427 999.0000 324.249435 2.6184 8.44 0.5872 32 ?
  324.2877777 777.0495 324.287570 1.7855 77.73 0.6403 31 ?
PK$NUM_PEAK: 3
PK$PEAK: m/z int. rel.int.
  149.023492 611.50 611
  324.249643 999.00 999
  324.287778 777.05 777
//
